Meng and colleagues evaluated angiogenesis in hepatocellular carcinoma upon knockdown of Hsp90α or Hsp90β, inhibiting the remaining isoform with an Hsp90 inhibitor. This evidence concerns the gene HSP90AB1 and hepatocellular carcinoma.